Skip to content
OpenCapital
Get started

Protara Therapeutics, Inc. TARA Q4 2024 Annual earnings

Reported March 5, 2025 · Before market open

EPS-$0.48Beat by $0.09
EPS estimate-$0.57

Next report

Aug 10, 2026 (In 1 week)
EPS estimate-$0.33

Versus estimates

Diluted EPS

Q1 2026-$0.31Beat by $0.05Q4 2025-$0.37Miss by $0.05Q3 2025-$0.31Beat by $0.08Q2 2025-$0.35Beat by $0.08Q1 2025-$0.29Beat by $0.18
Q4 2024-$0.48Beat by $0.09

Ask the moment Protara Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Protara Therapeutics, Inc. report Q4 2024 earnings?
Protara Therapeutics, Inc. (TARA) reported Q4 2024 earnings on March 5, 2025 before market open.
What were Protara Therapeutics, Inc.'s Q4 2024 revenue and EPS?
Protara Therapeutics, Inc. reported eps of $-0.48 for Q4 2024.
Did Protara Therapeutics, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.57 by $0.09.
Where can I find Protara Therapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001213900-25-020368) directly on SEC EDGAR. The filing index links above go to sec.gov.